Global Mirvetuximab Soravtansine Market Growth 2026-2032
The global Mirvetuximab Soravtansine market size is predicted to grow from US$ 675 million in 2025 to US$ 2623 million in 2032; it is expected to grow at a CAGR of 16.9% from 2026 to 2032.
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor ? (FR?). It is covalently formed by conjugating a humanized anti-FR? monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FR? on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FR?-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000?110,000 vials.
As a globally pioneering and the only approved FR?-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FR?-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
LP Information, Inc. (LPI) ' newest research report, the ?Mirvetuximab Soravtansine Industry Forecast? looks at past sales and reviews total world Mirvetuximab Soravtansine sales in 2025, providing a comprehensive analysis by region and market sector of projected Mirvetuximab Soravtansine sales for 2026 through 2032. With Mirvetuximab Soravtansine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mirvetuximab Soravtansine industry.
This Insight Report provides a comprehensive analysis of the global Mirvetuximab Soravtansine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mirvetuximab Soravtansine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mirvetuximab Soravtansine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mirvetuximab Soravtansine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mirvetuximab Soravtansine.
This report presents a comprehensive overview, market shares, and growth opportunities of Mirvetuximab Soravtansine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Mirvetuximab Soravtansine market?
What factors are driving Mirvetuximab Soravtansine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mirvetuximab Soravtansine market opportunities vary by end market size?
How does Mirvetuximab Soravtansine break out by Type, by Application?
Mirvetuximab Soravtansine is an antibody-drug conjugate (ADC) targeting folate receptor ? (FR?). It is covalently formed by conjugating a humanized anti-FR? monoclonal antibody, a cleavable linker, and the microtubule inhibitor DM4. The drug can specifically recognize and bind to highly expressed FR? on the surface of tumor cells, release cytotoxic payloads after endocytosis into cells, and precisely kill tumor cells. It is mainly used for the treatment of malignant tumors such as FR?-positive recurrent ovarian cancer. Featuring high targeting ability and strong anti-tumor activity, it provides an important targeted therapeutic option for patients with advanced ovarian cancer.In 2025, global Mirvetuximab Soravtansine production reached approximately 105,000?110,000 vials.
As a globally pioneering and the only approved FR?-targeted ADC drug, Mirvetuximab Soravtansine has established significant clinical and market advantages in the field of platinum-resistant ovarian cancer. Its core value lies in the high efficacy and low toxicity profile brought by its precise targeting mechanism, which effectively addresses the long-unmet clinical needs. The global market is mainly led by the United States, and with successive approvals and commercialization in major markets such as the European Union and China, the product has shown a trend of rapid growth. Supported by priority recommendations in authoritative guidelines, it has further driven continuous improvements in physician prescriptions and patient penetration. In China, the commercialization is led by Huadong Medicine, which has achieved early market access and rapid nationwide coverage through favorable innovative drug policies. The advantages of local channels and academic promotion are gradually unlocking market potential. Looking ahead, its market growth will rely on the continuous penetration of ovarian cancer indications on the one hand, and the potential clinical expansion into other FR?-highly-expressing tumors on the other. Meanwhile, it faces multiple constraints including limited accessibility due to high pricing, the progress of medical insurance coverage, and the development of competing products targeting the same target in the future. Overall, the market is expected to grow steadily while accompanied by uncertainties from competition and policy changes.
LP Information, Inc. (LPI) ' newest research report, the ?Mirvetuximab Soravtansine Industry Forecast? looks at past sales and reviews total world Mirvetuximab Soravtansine sales in 2025, providing a comprehensive analysis by region and market sector of projected Mirvetuximab Soravtansine sales for 2026 through 2032. With Mirvetuximab Soravtansine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mirvetuximab Soravtansine industry.
This Insight Report provides a comprehensive analysis of the global Mirvetuximab Soravtansine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mirvetuximab Soravtansine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Mirvetuximab Soravtansine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mirvetuximab Soravtansine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mirvetuximab Soravtansine.
This report presents a comprehensive overview, market shares, and growth opportunities of Mirvetuximab Soravtansine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Lyophilized Powder for Injection
- Injectable Solution
- Mirvetuximab Soravtansine In Combination With Bevacizumab
- Mirvetuximab Soravtansine In Combination With Carboplatin
- Hospital
- Retail
- Online
- FR?-Positive Recurrent Ovarian Cancer
- Platinum-Resistant Epithelial Ovarian Cancer
- FR?-Highly Expressed Advanced Solid Tumors
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Hangzhou Sino-American East China Pharmaceutical
What is the 10-year outlook for the global Mirvetuximab Soravtansine market?
What factors are driving Mirvetuximab Soravtansine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mirvetuximab Soravtansine market opportunities vary by end market size?
How does Mirvetuximab Soravtansine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mirvetuximab Soravtansine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mirvetuximab Soravtansine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mirvetuximab Soravtansine by Country/Region, 2021, 2025 & 2032
2.2 Mirvetuximab Soravtansine Segment by Type
2.2.1 Lyophilized Powder for Injection
2.2.2 Injectable Solution
2.2.3 Mirvetuximab Soravtansine Sales by Type
2.2.3.1 Global Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Mirvetuximab Soravtansine Sale Price by Type (2021-2026)
2.3 Mirvetuximab Soravtansine Segment by Combination Medication
2.3.1 Mirvetuximab Soravtansine In Combination With Bevacizumab
2.3.2 Mirvetuximab Soravtansine In Combination With Carboplatin
2.3.3 Mirvetuximab Soravtansine Sales by Combination Medication
2.3.3.1 Global Mirvetuximab Soravtansine Sales Market Share by Combination Medication (2021-2026)
2.3.3.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Combination Medication (2021-2026)
2.3.3.3 Global Mirvetuximab Soravtansine Sale Price by Combination Medication (2021-2026)
2.4 Mirvetuximab Soravtansine Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Mirvetuximab Soravtansine Sales by Sales Channels
2.4.4.1 Global Mirvetuximab Soravtansine Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Mirvetuximab Soravtansine Sale Price by Sales Channels (2021-2026)
2.5 Mirvetuximab Soravtansine Segment by Application
2.5.1 FR?-Positive Recurrent Ovarian Cancer
2.5.2 Platinum-Resistant Epithelial Ovarian Cancer
2.5.3 FR?-Highly Expressed Advanced Solid Tumors
2.5.4 Others
2.5.5 Mirvetuximab Soravtansine Sales by Application
2.5.5.1 Global Mirvetuximab Soravtansine Sale Market Share by Application (2021-2026)
2.5.5.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Mirvetuximab Soravtansine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mirvetuximab Soravtansine Breakdown Data by Company
3.1.1 Global Mirvetuximab Soravtansine Annual Sales by Company (2021-2026)
3.1.2 Global Mirvetuximab Soravtansine Sales Market Share by Company (2021-2026)
3.2 Global Mirvetuximab Soravtansine Annual Revenue by Company (2021-2026)
3.2.1 Global Mirvetuximab Soravtansine Revenue by Company (2021-2026)
3.2.2 Global Mirvetuximab Soravtansine Revenue Market Share by Company (2021-2026)
3.3 Global Mirvetuximab Soravtansine Sale Price by Company
3.4 Key Manufacturers Mirvetuximab Soravtansine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mirvetuximab Soravtansine Product Location Distribution
3.4.2 Players Mirvetuximab Soravtansine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MIRVETUXIMAB SORAVTANSINE BY GEOGRAPHIC REGION
4.1 World Historic Mirvetuximab Soravtansine Market Size by Geographic Region (2021-2026)
4.1.1 Global Mirvetuximab Soravtansine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mirvetuximab Soravtansine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mirvetuximab Soravtansine Market Size by Country/Region (2021-2026)
4.2.1 Global Mirvetuximab Soravtansine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mirvetuximab Soravtansine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mirvetuximab Soravtansine Sales Growth
4.4 APAC Mirvetuximab Soravtansine Sales Growth
4.5 Europe Mirvetuximab Soravtansine Sales Growth
4.6 Middle East & Africa Mirvetuximab Soravtansine Sales Growth
5 AMERICAS
5.1 Americas Mirvetuximab Soravtansine Sales by Country
5.1.1 Americas Mirvetuximab Soravtansine Sales by Country (2021-2026)
5.1.2 Americas Mirvetuximab Soravtansine Revenue by Country (2021-2026)
5.2 Americas Mirvetuximab Soravtansine Sales by Type (2021-2026)
5.3 Americas Mirvetuximab Soravtansine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mirvetuximab Soravtansine Sales by Region
6.1.1 APAC Mirvetuximab Soravtansine Sales by Region (2021-2026)
6.1.2 APAC Mirvetuximab Soravtansine Revenue by Region (2021-2026)
6.2 APAC Mirvetuximab Soravtansine Sales by Type (2021-2026)
6.3 APAC Mirvetuximab Soravtansine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mirvetuximab Soravtansine by Country
7.1.1 Europe Mirvetuximab Soravtansine Sales by Country (2021-2026)
7.1.2 Europe Mirvetuximab Soravtansine Revenue by Country (2021-2026)
7.2 Europe Mirvetuximab Soravtansine Sales by Type (2021-2026)
7.3 Europe Mirvetuximab Soravtansine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mirvetuximab Soravtansine by Country
8.1.1 Middle East & Africa Mirvetuximab Soravtansine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mirvetuximab Soravtansine Revenue by Country (2021-2026)
8.2 Middle East & Africa Mirvetuximab Soravtansine Sales by Type (2021-2026)
8.3 Middle East & Africa Mirvetuximab Soravtansine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mirvetuximab Soravtansine
10.3 Manufacturing Process Analysis of Mirvetuximab Soravtansine
10.4 Industry Chain Structure of Mirvetuximab Soravtansine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mirvetuximab Soravtansine Distributors
11.3 Mirvetuximab Soravtansine Customer
12 WORLD FORECAST REVIEW FOR MIRVETUXIMAB SORAVTANSINE BY GEOGRAPHIC REGION
12.1 Global Mirvetuximab Soravtansine Market Size Forecast by Region
12.1.1 Global Mirvetuximab Soravtansine Forecast by Region (2027-2032)
12.1.2 Global Mirvetuximab Soravtansine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mirvetuximab Soravtansine Forecast by Type (2027-2032)
12.7 Global Mirvetuximab Soravtansine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Mirvetuximab Soravtansine Product Portfolios and Specifications
13.1.3 AbbVie Mirvetuximab Soravtansine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Hangzhou Sino-American East China Pharmaceutical
13.2.1 Hangzhou Sino-American East China Pharmaceutical Company Information
13.2.2 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product Portfolios and Specifications
13.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hangzhou Sino-American East China Pharmaceutical Main Business Overview
13.2.5 Hangzhou Sino-American East China Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mirvetuximab Soravtansine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Mirvetuximab Soravtansine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Mirvetuximab Soravtansine by Country/Region, 2021, 2025 & 2032
2.2 Mirvetuximab Soravtansine Segment by Type
2.2.1 Lyophilized Powder for Injection
2.2.2 Injectable Solution
2.2.3 Mirvetuximab Soravtansine Sales by Type
2.2.3.1 Global Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Mirvetuximab Soravtansine Sale Price by Type (2021-2026)
2.3 Mirvetuximab Soravtansine Segment by Combination Medication
2.3.1 Mirvetuximab Soravtansine In Combination With Bevacizumab
2.3.2 Mirvetuximab Soravtansine In Combination With Carboplatin
2.3.3 Mirvetuximab Soravtansine Sales by Combination Medication
2.3.3.1 Global Mirvetuximab Soravtansine Sales Market Share by Combination Medication (2021-2026)
2.3.3.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Combination Medication (2021-2026)
2.3.3.3 Global Mirvetuximab Soravtansine Sale Price by Combination Medication (2021-2026)
2.4 Mirvetuximab Soravtansine Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Mirvetuximab Soravtansine Sales by Sales Channels
2.4.4.1 Global Mirvetuximab Soravtansine Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Mirvetuximab Soravtansine Sale Price by Sales Channels (2021-2026)
2.5 Mirvetuximab Soravtansine Segment by Application
2.5.1 FR?-Positive Recurrent Ovarian Cancer
2.5.2 Platinum-Resistant Epithelial Ovarian Cancer
2.5.3 FR?-Highly Expressed Advanced Solid Tumors
2.5.4 Others
2.5.5 Mirvetuximab Soravtansine Sales by Application
2.5.5.1 Global Mirvetuximab Soravtansine Sale Market Share by Application (2021-2026)
2.5.5.2 Global Mirvetuximab Soravtansine Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Mirvetuximab Soravtansine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Mirvetuximab Soravtansine Breakdown Data by Company
3.1.1 Global Mirvetuximab Soravtansine Annual Sales by Company (2021-2026)
3.1.2 Global Mirvetuximab Soravtansine Sales Market Share by Company (2021-2026)
3.2 Global Mirvetuximab Soravtansine Annual Revenue by Company (2021-2026)
3.2.1 Global Mirvetuximab Soravtansine Revenue by Company (2021-2026)
3.2.2 Global Mirvetuximab Soravtansine Revenue Market Share by Company (2021-2026)
3.3 Global Mirvetuximab Soravtansine Sale Price by Company
3.4 Key Manufacturers Mirvetuximab Soravtansine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mirvetuximab Soravtansine Product Location Distribution
3.4.2 Players Mirvetuximab Soravtansine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MIRVETUXIMAB SORAVTANSINE BY GEOGRAPHIC REGION
4.1 World Historic Mirvetuximab Soravtansine Market Size by Geographic Region (2021-2026)
4.1.1 Global Mirvetuximab Soravtansine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Mirvetuximab Soravtansine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Mirvetuximab Soravtansine Market Size by Country/Region (2021-2026)
4.2.1 Global Mirvetuximab Soravtansine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Mirvetuximab Soravtansine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Mirvetuximab Soravtansine Sales Growth
4.4 APAC Mirvetuximab Soravtansine Sales Growth
4.5 Europe Mirvetuximab Soravtansine Sales Growth
4.6 Middle East & Africa Mirvetuximab Soravtansine Sales Growth
5 AMERICAS
5.1 Americas Mirvetuximab Soravtansine Sales by Country
5.1.1 Americas Mirvetuximab Soravtansine Sales by Country (2021-2026)
5.1.2 Americas Mirvetuximab Soravtansine Revenue by Country (2021-2026)
5.2 Americas Mirvetuximab Soravtansine Sales by Type (2021-2026)
5.3 Americas Mirvetuximab Soravtansine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mirvetuximab Soravtansine Sales by Region
6.1.1 APAC Mirvetuximab Soravtansine Sales by Region (2021-2026)
6.1.2 APAC Mirvetuximab Soravtansine Revenue by Region (2021-2026)
6.2 APAC Mirvetuximab Soravtansine Sales by Type (2021-2026)
6.3 APAC Mirvetuximab Soravtansine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mirvetuximab Soravtansine by Country
7.1.1 Europe Mirvetuximab Soravtansine Sales by Country (2021-2026)
7.1.2 Europe Mirvetuximab Soravtansine Revenue by Country (2021-2026)
7.2 Europe Mirvetuximab Soravtansine Sales by Type (2021-2026)
7.3 Europe Mirvetuximab Soravtansine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mirvetuximab Soravtansine by Country
8.1.1 Middle East & Africa Mirvetuximab Soravtansine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Mirvetuximab Soravtansine Revenue by Country (2021-2026)
8.2 Middle East & Africa Mirvetuximab Soravtansine Sales by Type (2021-2026)
8.3 Middle East & Africa Mirvetuximab Soravtansine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mirvetuximab Soravtansine
10.3 Manufacturing Process Analysis of Mirvetuximab Soravtansine
10.4 Industry Chain Structure of Mirvetuximab Soravtansine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mirvetuximab Soravtansine Distributors
11.3 Mirvetuximab Soravtansine Customer
12 WORLD FORECAST REVIEW FOR MIRVETUXIMAB SORAVTANSINE BY GEOGRAPHIC REGION
12.1 Global Mirvetuximab Soravtansine Market Size Forecast by Region
12.1.1 Global Mirvetuximab Soravtansine Forecast by Region (2027-2032)
12.1.2 Global Mirvetuximab Soravtansine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Mirvetuximab Soravtansine Forecast by Type (2027-2032)
12.7 Global Mirvetuximab Soravtansine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Mirvetuximab Soravtansine Product Portfolios and Specifications
13.1.3 AbbVie Mirvetuximab Soravtansine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Hangzhou Sino-American East China Pharmaceutical
13.2.1 Hangzhou Sino-American East China Pharmaceutical Company Information
13.2.2 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product Portfolios and Specifications
13.2.3 Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Hangzhou Sino-American East China Pharmaceutical Main Business Overview
13.2.5 Hangzhou Sino-American East China Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mirvetuximab Soravtansine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mirvetuximab Soravtansine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lyophilized Powder for Injection
Table 4. Major Players of Injectable Solution
Table 5. Global Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 6. Global Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Table 7. Global Mirvetuximab Soravtansine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mirvetuximab Soravtansine Revenue Market Share by Type (2021-2026)
Table 9. Global Mirvetuximab Soravtansine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Mirvetuximab Soravtansine In Combination With Bevacizumab
Table 11. Major Players of Mirvetuximab Soravtansine In Combination With Carboplatin
Table 12. Global Mirvetuximab Soravtansine Sales by Combination Medication (2021-2026) & (Units)
Table 13. Global Mirvetuximab Soravtansine Sales Market Share by Combination Medication (2021-2026)
Table 14. Global Mirvetuximab Soravtansine Revenue by Combination Medication (2021-2026) & ($ million)
Table 15. Global Mirvetuximab Soravtansine Revenue Market Share by Combination Medication (2021-2026)
Table 16. Global Mirvetuximab Soravtansine Sale Price by Combination Medication (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Mirvetuximab Soravtansine Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global Mirvetuximab Soravtansine Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Mirvetuximab Soravtansine Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Mirvetuximab Soravtansine Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Mirvetuximab Soravtansine Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Global Mirvetuximab Soravtansine Sale by Application (2021-2026) & (Units)
Table 26. Global Mirvetuximab Soravtansine Sale Market Share by Application (2021-2026)
Table 27. Global Mirvetuximab Soravtansine Revenue by Application (2021-2026) & ($ million)
Table 28. Global Mirvetuximab Soravtansine Revenue Market Share by Application (2021-2026)
Table 29. Global Mirvetuximab Soravtansine Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Mirvetuximab Soravtansine Sales by Company (2021-2026) & (Units)
Table 31. Global Mirvetuximab Soravtansine Sales Market Share by Company (2021-2026)
Table 32. Global Mirvetuximab Soravtansine Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Mirvetuximab Soravtansine Revenue Market Share by Company (2021-2026)
Table 34. Global Mirvetuximab Soravtansine Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Mirvetuximab Soravtansine Producing Area Distribution and Sales Area
Table 36. Players Mirvetuximab Soravtansine Products Offered
Table 37. Mirvetuximab Soravtansine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Mirvetuximab Soravtansine Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Mirvetuximab Soravtansine Sales Market Share Geographic Region (2021-2026)
Table 42. Global Mirvetuximab Soravtansine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Mirvetuximab Soravtansine Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Mirvetuximab Soravtansine Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Mirvetuximab Soravtansine Sales Market Share by Country/Region (2021-2026)
Table 46. Global Mirvetuximab Soravtansine Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Mirvetuximab Soravtansine Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Mirvetuximab Soravtansine Sales by Country (2021-2026) & (Units)
Table 49. Americas Mirvetuximab Soravtansine Sales Market Share by Country (2021-2026)
Table 50. Americas Mirvetuximab Soravtansine Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 52. Americas Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 53. APAC Mirvetuximab Soravtansine Sales by Region (2021-2026) & (Units)
Table 54. APAC Mirvetuximab Soravtansine Sales Market Share by Region (2021-2026)
Table 55. APAC Mirvetuximab Soravtansine Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 57. APAC Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 58. Europe Mirvetuximab Soravtansine Sales by Country (2021-2026) & (Units)
Table 59. Europe Mirvetuximab Soravtansine Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 61. Europe Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Mirvetuximab Soravtansine Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Mirvetuximab Soravtansine Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Mirvetuximab Soravtansine
Table 67. Key Market Challenges & Risks of Mirvetuximab Soravtansine
Table 68. Key Industry Trends of Mirvetuximab Soravtansine
Table 69. Mirvetuximab Soravtansine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Mirvetuximab Soravtansine Distributors List
Table 72. Mirvetuximab Soravtansine Customer List
Table 73. Global Mirvetuximab Soravtansine Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Mirvetuximab Soravtansine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Mirvetuximab Soravtansine Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Mirvetuximab Soravtansine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Mirvetuximab Soravtansine Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Mirvetuximab Soravtansine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Mirvetuximab Soravtansine Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Mirvetuximab Soravtansine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Mirvetuximab Soravtansine Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Mirvetuximab Soravtansine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Mirvetuximab Soravtansine Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Mirvetuximab Soravtansine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Mirvetuximab Soravtansine Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Mirvetuximab Soravtansine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. AbbVie Basic Information, Mirvetuximab Soravtansine Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Mirvetuximab Soravtansine Product Portfolios and Specifications
Table 89. AbbVie Mirvetuximab Soravtansine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Hangzhou Sino-American East China Pharmaceutical Basic Information, Mirvetuximab Soravtansine Manufacturing Base, Sales Area and Its Competitors
Table 93. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product Portfolios and Specifications
Table 94. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hangzhou Sino-American East China Pharmaceutical Main Business
Table 96. Hangzhou Sino-American East China Pharmaceutical Latest Developments
Table 1. Mirvetuximab Soravtansine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Mirvetuximab Soravtansine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Lyophilized Powder for Injection
Table 4. Major Players of Injectable Solution
Table 5. Global Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 6. Global Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Table 7. Global Mirvetuximab Soravtansine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Mirvetuximab Soravtansine Revenue Market Share by Type (2021-2026)
Table 9. Global Mirvetuximab Soravtansine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Mirvetuximab Soravtansine In Combination With Bevacizumab
Table 11. Major Players of Mirvetuximab Soravtansine In Combination With Carboplatin
Table 12. Global Mirvetuximab Soravtansine Sales by Combination Medication (2021-2026) & (Units)
Table 13. Global Mirvetuximab Soravtansine Sales Market Share by Combination Medication (2021-2026)
Table 14. Global Mirvetuximab Soravtansine Revenue by Combination Medication (2021-2026) & ($ million)
Table 15. Global Mirvetuximab Soravtansine Revenue Market Share by Combination Medication (2021-2026)
Table 16. Global Mirvetuximab Soravtansine Sale Price by Combination Medication (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global Mirvetuximab Soravtansine Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global Mirvetuximab Soravtansine Sales Market Share by Sales Channels (2021-2026)
Table 22. Global Mirvetuximab Soravtansine Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global Mirvetuximab Soravtansine Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global Mirvetuximab Soravtansine Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Global Mirvetuximab Soravtansine Sale by Application (2021-2026) & (Units)
Table 26. Global Mirvetuximab Soravtansine Sale Market Share by Application (2021-2026)
Table 27. Global Mirvetuximab Soravtansine Revenue by Application (2021-2026) & ($ million)
Table 28. Global Mirvetuximab Soravtansine Revenue Market Share by Application (2021-2026)
Table 29. Global Mirvetuximab Soravtansine Sale Price by Application (2021-2026) & (US$/Unit)
Table 30. Global Mirvetuximab Soravtansine Sales by Company (2021-2026) & (Units)
Table 31. Global Mirvetuximab Soravtansine Sales Market Share by Company (2021-2026)
Table 32. Global Mirvetuximab Soravtansine Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Mirvetuximab Soravtansine Revenue Market Share by Company (2021-2026)
Table 34. Global Mirvetuximab Soravtansine Sale Price by Company (2021-2026) & (US$/Unit)
Table 35. Key Manufacturers Mirvetuximab Soravtansine Producing Area Distribution and Sales Area
Table 36. Players Mirvetuximab Soravtansine Products Offered
Table 37. Mirvetuximab Soravtansine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Mirvetuximab Soravtansine Sales by Geographic Region (2021-2026) & (Units)
Table 41. Global Mirvetuximab Soravtansine Sales Market Share Geographic Region (2021-2026)
Table 42. Global Mirvetuximab Soravtansine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Mirvetuximab Soravtansine Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Mirvetuximab Soravtansine Sales by Country/Region (2021-2026) & (Units)
Table 45. Global Mirvetuximab Soravtansine Sales Market Share by Country/Region (2021-2026)
Table 46. Global Mirvetuximab Soravtansine Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Mirvetuximab Soravtansine Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Mirvetuximab Soravtansine Sales by Country (2021-2026) & (Units)
Table 49. Americas Mirvetuximab Soravtansine Sales Market Share by Country (2021-2026)
Table 50. Americas Mirvetuximab Soravtansine Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 52. Americas Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 53. APAC Mirvetuximab Soravtansine Sales by Region (2021-2026) & (Units)
Table 54. APAC Mirvetuximab Soravtansine Sales Market Share by Region (2021-2026)
Table 55. APAC Mirvetuximab Soravtansine Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 57. APAC Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 58. Europe Mirvetuximab Soravtansine Sales by Country (2021-2026) & (Units)
Table 59. Europe Mirvetuximab Soravtansine Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 61. Europe Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 62. Middle East & Africa Mirvetuximab Soravtansine Sales by Country (2021-2026) & (Units)
Table 63. Middle East & Africa Mirvetuximab Soravtansine Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Mirvetuximab Soravtansine Sales by Type (2021-2026) & (Units)
Table 65. Middle East & Africa Mirvetuximab Soravtansine Sales by Application (2021-2026) & (Units)
Table 66. Key Market Drivers & Growth Opportunities of Mirvetuximab Soravtansine
Table 67. Key Market Challenges & Risks of Mirvetuximab Soravtansine
Table 68. Key Industry Trends of Mirvetuximab Soravtansine
Table 69. Mirvetuximab Soravtansine Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Mirvetuximab Soravtansine Distributors List
Table 72. Mirvetuximab Soravtansine Customer List
Table 73. Global Mirvetuximab Soravtansine Sales Forecast by Region (2027-2032) & (Units)
Table 74. Global Mirvetuximab Soravtansine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Mirvetuximab Soravtansine Sales Forecast by Country (2027-2032) & (Units)
Table 76. Americas Mirvetuximab Soravtansine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Mirvetuximab Soravtansine Sales Forecast by Region (2027-2032) & (Units)
Table 78. APAC Mirvetuximab Soravtansine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Mirvetuximab Soravtansine Sales Forecast by Country (2027-2032) & (Units)
Table 80. Europe Mirvetuximab Soravtansine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Mirvetuximab Soravtansine Sales Forecast by Country (2027-2032) & (Units)
Table 82. Middle East & Africa Mirvetuximab Soravtansine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Mirvetuximab Soravtansine Sales Forecast by Type (2027-2032) & (Units)
Table 84. Global Mirvetuximab Soravtansine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 85. Global Mirvetuximab Soravtansine Sales Forecast by Application (2027-2032) & (Units)
Table 86. Global Mirvetuximab Soravtansine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. AbbVie Basic Information, Mirvetuximab Soravtansine Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Mirvetuximab Soravtansine Product Portfolios and Specifications
Table 89. AbbVie Mirvetuximab Soravtansine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Hangzhou Sino-American East China Pharmaceutical Basic Information, Mirvetuximab Soravtansine Manufacturing Base, Sales Area and Its Competitors
Table 93. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Product Portfolios and Specifications
Table 94. Hangzhou Sino-American East China Pharmaceutical Mirvetuximab Soravtansine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hangzhou Sino-American East China Pharmaceutical Main Business
Table 96. Hangzhou Sino-American East China Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mirvetuximab Soravtansine
Figure 2. Mirvetuximab Soravtansine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mirvetuximab Soravtansine Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Mirvetuximab Soravtansine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mirvetuximab Soravtansine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mirvetuximab Soravtansine Sales Market Share by Country/Region (2025)
Figure 10. Mirvetuximab Soravtansine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lyophilized Powder for Injection
Figure 12. Product Picture of Injectable Solution
Figure 13. Global Mirvetuximab Soravtansine Sales Market Share by Type in 2026
Figure 14. Global Mirvetuximab Soravtansine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Mirvetuximab Soravtansine In Combination With Bevacizumab
Figure 16. Product Picture of Mirvetuximab Soravtansine In Combination With Carboplatin
Figure 17. Global Mirvetuximab Soravtansine Sales Market Share by Combination Medication in 2026
Figure 18. Global Mirvetuximab Soravtansine Revenue Market Share by Combination Medication (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Mirvetuximab Soravtansine Sales Market Share by Sales Channels in 2026
Figure 23. Global Mirvetuximab Soravtansine Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Mirvetuximab Soravtansine Consumed in FR?-Positive Recurrent Ovarian Cancer
Figure 25. Global Mirvetuximab Soravtansine Market: FR?-Positive Recurrent Ovarian Cancer (2021-2026) & (Units)
Figure 26. Mirvetuximab Soravtansine Consumed in Platinum-Resistant Epithelial Ovarian Cancer
Figure 27. Global Mirvetuximab Soravtansine Market: Platinum-Resistant Epithelial Ovarian Cancer (2021-2026) & (Units)
Figure 28. Mirvetuximab Soravtansine Consumed in FR?-Highly Expressed Advanced Solid Tumors
Figure 29. Global Mirvetuximab Soravtansine Market: FR?-Highly Expressed Advanced Solid Tumors (2021-2026) & (Units)
Figure 30. Mirvetuximab Soravtansine Consumed in Others
Figure 31. Global Mirvetuximab Soravtansine Market: Others (2021-2026) & (Units)
Figure 32. Global Mirvetuximab Soravtansine Sale Market Share by Application (2025)
Figure 33. Global Mirvetuximab Soravtansine Revenue Market Share by Application in 2025
Figure 34. Mirvetuximab Soravtansine Sales by Company in 2025 (Units)
Figure 35. Global Mirvetuximab Soravtansine Sales Market Share by Company in 2025
Figure 36. Mirvetuximab Soravtansine Revenue by Company in 2025 ($ millions)
Figure 37. Global Mirvetuximab Soravtansine Revenue Market Share by Company in 2025
Figure 38. Global Mirvetuximab Soravtansine Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Mirvetuximab Soravtansine Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 41. Americas Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 42. APAC Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 43. APAC Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 44. Europe Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 45. Europe Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 48. Americas Mirvetuximab Soravtansine Sales Market Share by Country in 2025
Figure 49. Americas Mirvetuximab Soravtansine Revenue Market Share by Country (2021-2026)
Figure 50. Americas Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 51. Americas Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 52. United States Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Mirvetuximab Soravtansine Sales Market Share by Region in 2025
Figure 57. APAC Mirvetuximab Soravtansine Revenue Market Share by Region (2021-2026)
Figure 58. APAC Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 59. APAC Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 60. China Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 64. India Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Mirvetuximab Soravtansine Sales Market Share by Country in 2025
Figure 68. Europe Mirvetuximab Soravtansine Revenue Market Share by Country (2021-2026)
Figure 69. Europe Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 70. Europe Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 71. Germany Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 72. France Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Mirvetuximab Soravtansine Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 79. Egypt Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Mirvetuximab Soravtansine in 2026
Figure 85. Manufacturing Process Analysis of Mirvetuximab Soravtansine
Figure 86. Industry Chain Structure of Mirvetuximab Soravtansine
Figure 87. Channels of Distribution
Figure 88. Global Mirvetuximab Soravtansine Sales Market Forecast by Region (2027-2032)
Figure 89. Global Mirvetuximab Soravtansine Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Mirvetuximab Soravtansine Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Mirvetuximab Soravtansine Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Mirvetuximab Soravtansine Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Mirvetuximab Soravtansine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Mirvetuximab Soravtansine
Figure 2. Mirvetuximab Soravtansine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mirvetuximab Soravtansine Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Mirvetuximab Soravtansine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Mirvetuximab Soravtansine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Mirvetuximab Soravtansine Sales Market Share by Country/Region (2025)
Figure 10. Mirvetuximab Soravtansine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Lyophilized Powder for Injection
Figure 12. Product Picture of Injectable Solution
Figure 13. Global Mirvetuximab Soravtansine Sales Market Share by Type in 2026
Figure 14. Global Mirvetuximab Soravtansine Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Mirvetuximab Soravtansine In Combination With Bevacizumab
Figure 16. Product Picture of Mirvetuximab Soravtansine In Combination With Carboplatin
Figure 17. Global Mirvetuximab Soravtansine Sales Market Share by Combination Medication in 2026
Figure 18. Global Mirvetuximab Soravtansine Revenue Market Share by Combination Medication (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global Mirvetuximab Soravtansine Sales Market Share by Sales Channels in 2026
Figure 23. Global Mirvetuximab Soravtansine Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Mirvetuximab Soravtansine Consumed in FR?-Positive Recurrent Ovarian Cancer
Figure 25. Global Mirvetuximab Soravtansine Market: FR?-Positive Recurrent Ovarian Cancer (2021-2026) & (Units)
Figure 26. Mirvetuximab Soravtansine Consumed in Platinum-Resistant Epithelial Ovarian Cancer
Figure 27. Global Mirvetuximab Soravtansine Market: Platinum-Resistant Epithelial Ovarian Cancer (2021-2026) & (Units)
Figure 28. Mirvetuximab Soravtansine Consumed in FR?-Highly Expressed Advanced Solid Tumors
Figure 29. Global Mirvetuximab Soravtansine Market: FR?-Highly Expressed Advanced Solid Tumors (2021-2026) & (Units)
Figure 30. Mirvetuximab Soravtansine Consumed in Others
Figure 31. Global Mirvetuximab Soravtansine Market: Others (2021-2026) & (Units)
Figure 32. Global Mirvetuximab Soravtansine Sale Market Share by Application (2025)
Figure 33. Global Mirvetuximab Soravtansine Revenue Market Share by Application in 2025
Figure 34. Mirvetuximab Soravtansine Sales by Company in 2025 (Units)
Figure 35. Global Mirvetuximab Soravtansine Sales Market Share by Company in 2025
Figure 36. Mirvetuximab Soravtansine Revenue by Company in 2025 ($ millions)
Figure 37. Global Mirvetuximab Soravtansine Revenue Market Share by Company in 2025
Figure 38. Global Mirvetuximab Soravtansine Sales Market Share by Geographic Region (2021-2026)
Figure 39. Global Mirvetuximab Soravtansine Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 41. Americas Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 42. APAC Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 43. APAC Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 44. Europe Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 45. Europe Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 46. Middle East & Africa Mirvetuximab Soravtansine Sales 2021-2026 (Units)
Figure 47. Middle East & Africa Mirvetuximab Soravtansine Revenue 2021-2026 ($ millions)
Figure 48. Americas Mirvetuximab Soravtansine Sales Market Share by Country in 2025
Figure 49. Americas Mirvetuximab Soravtansine Revenue Market Share by Country (2021-2026)
Figure 50. Americas Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 51. Americas Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 52. United States Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 53. Canada Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 54. Mexico Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 55. Brazil Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 56. APAC Mirvetuximab Soravtansine Sales Market Share by Region in 2025
Figure 57. APAC Mirvetuximab Soravtansine Revenue Market Share by Region (2021-2026)
Figure 58. APAC Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 59. APAC Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 60. China Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 61. Japan Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 62. South Korea Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 63. Southeast Asia Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 64. India Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 65. Australia Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 66. China Taiwan Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 67. Europe Mirvetuximab Soravtansine Sales Market Share by Country in 2025
Figure 68. Europe Mirvetuximab Soravtansine Revenue Market Share by Country (2021-2026)
Figure 69. Europe Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 70. Europe Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 71. Germany Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 72. France Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 73. UK Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 74. Italy Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 75. Russia Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 76. Middle East & Africa Mirvetuximab Soravtansine Sales Market Share by Country (2021-2026)
Figure 77. Middle East & Africa Mirvetuximab Soravtansine Sales Market Share by Type (2021-2026)
Figure 78. Middle East & Africa Mirvetuximab Soravtansine Sales Market Share by Application (2021-2026)
Figure 79. Egypt Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 80. South Africa Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 81. Israel Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 82. Turkey Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 83. GCC Countries Mirvetuximab Soravtansine Revenue Growth 2021-2026 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Mirvetuximab Soravtansine in 2026
Figure 85. Manufacturing Process Analysis of Mirvetuximab Soravtansine
Figure 86. Industry Chain Structure of Mirvetuximab Soravtansine
Figure 87. Channels of Distribution
Figure 88. Global Mirvetuximab Soravtansine Sales Market Forecast by Region (2027-2032)
Figure 89. Global Mirvetuximab Soravtansine Revenue Market Share Forecast by Region (2027-2032)
Figure 90. Global Mirvetuximab Soravtansine Sales Market Share Forecast by Type (2027-2032)
Figure 91. Global Mirvetuximab Soravtansine Revenue Market Share Forecast by Type (2027-2032)
Figure 92. Global Mirvetuximab Soravtansine Sales Market Share Forecast by Application (2027-2032)
Figure 93. Global Mirvetuximab Soravtansine Revenue Market Share Forecast by Application (2027-2032)
